Rabies Diagnostics Market Size, Share And Outlook By 2033

The new report published by The Business Research Company, titled ""Rabies Diagnostics Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the rabies diagnostics market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.3%. The rabies diagnostics market size is expected to see strong growth in the next few years. It will grow to $2.19 billion in 2028 at a compound annual growth rate (CAGR) of 6.5%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=8476&type=smp

Increasing Prevalence Of Rabies Propel The Growth Of The Market For Rabies
The increasing prevalence of rabies is expected to propel the growth of the market for rabies diagnostics. Rabies is a preventable viral illness that is most commonly spread via a rabid animal's bite. The rabies virus attacks mammals' central nervous systems, eventually causing brain damage and leading to death. Rabies diagnosis is used to detect the rabies virus in humans and animals using a variety of diagnostic tests and techniques. Additionally, the rising cases of infectious animal-transmitted diseases have favored the demand for rabies diagnostics. For instance, in May 2021, according to the report published by the World Health Organization, a Switzerland-based agency for international public health states that every year, rabies kills around 59,000 people globally, and more than 29 million people worldwide receive a post-bite vaccine. Rabies is estimated to cost the world $8.6 billion each year. Therefore, the increasing prevalence of rabies will drive the rabies diagnostics market.

Product Innovation In Rabies Diagnostics Market
Product innovation has emerged as a key trend gaining popularity in the rabies diagnostics market. Innovation and development of efficient testing techniques in the field of analytical chemistry designed to provide accurate and cost-effective analytical solutions are being adopted by pharmaceutical manufacturers all around the globe. These testing products are efficiently integrated into the regular sample testing process. For instance, in May 2022, Bio-Rad Laboratories Inc., a US-based developer, and manufacturer of specialized technology products launched the CFX Duet Real-Time PCR system, a clinical diagnostic device designed to aid researchers in the development of singleplex and duplex quantitative PCR (qPCR) tests. The unique features of the product provide improved thermal performance, as well as a patented, precise optical shuttle system and thermal gradient functionality for optimization.

The rabies diagnostics market covered in this report is segmented -

1) By Diagnostic Method: Fluorescent Antibody Test, Immunohistochemical Test, Amplification Methods, Histologic Examination, Serology Tests
2) By Technology: ELISA/Immunohistochemistry, Chromatography Techniques, PCR, Other Technologies
3) By End-User: Hospital, Diagnostic Centres, Cancer Palliative Care Clinics, Other End-Users

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=8476&type=discount

Major companies operating in the rabies diagnostics market report are Bio-Rad Laboratories Inc., The Merck Group, Aviva Systems Biology Corporation, Creative Diagnostics, Demeditec Diagnostics GmbH, Abbexa Ltd., Norgen Biotek Corp., BioNote Inc., Express Biotech International Inc., MyBioSource Inc., QIAGEN N.V., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies Inc., Fluidigm Corp., Bio-X Diagnostics S.A., Fujirebio Diagnostics Inc., Gold Standard Diagnostics Corp., Heska Corporation, IDEXX Laboratories Inc., InBios International Inc., KHB Shanghai Kehua Bio-Engineering Co. Ltd., Meridian Bioscience Inc., MP Biomedicals LLC, Neogen Corporation, Randox Laboratories Ltd., SDIX LLC, Sigma-Aldrich Corporation, Virbac Animal health Pvt. Ltd., Zoetis Inc.

Contents of the report:
1. Executive Summary
2. Rabies Diagnostics Market Report Structure
3. Rabies Diagnostics Market Trends And Strategies
4. Rabies Diagnostics Market - Macro Economic Scenario
5. Rabies Diagnostics Market Size And Growth
…..
27. Rabies Diagnostics Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/rabies-diagnostics-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.